Mojca Jensterle

Ljubljana, 1000, Slovenia

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 93 publications

Unmasking Indolent Systemic Mastocytosis in Patients with Unexplained or Treatment-Refractory Osteoporosis: A Case Series with Diagnostic and Therapeutic Implications.

Unmasking Indolent Systemic Mastocytosis in Patients with Unexplained or Treatment-Refractory Osteoporosis: A Case Series with Diagnostic and Therapeutic Implications.

Journal: Biomolecules

Published: April 26, 2026

Incretin-Based Medications in Women and Reproduction: A Systematic Scoping Review and Consensus Guidelines for Clinical Practice.

Incretin-Based Medications in Women and Reproduction: A Systematic Scoping Review and Consensus Guidelines for Clinical Practice.

Journal: Obesity reviews : an official journal of the International Association for the Study of Obesity

Published: February 12, 2026

Persistence-Dependent Effectiveness of Tirzepatide on the Cardio-Metabolic-Kidney Syndrome Outcomes in Obesity: Real-World Evidence from the United Arab Emirates.

Persistence-Dependent Effectiveness of Tirzepatide on the Cardio-Metabolic-Kidney Syndrome Outcomes in Obesity: Real-World Evidence from the United Arab Emirates.

Journal: Diabetes therapy : research, treatment and education of diabetes and related disorders

Published: February 03, 2026

Obesity-Related Functional Hypogonadism Requires Therapeutic Recalibration: Implications for GLP-1-Based Therapies.

Obesity-Related Functional Hypogonadism Requires Therapeutic Recalibration: Implications for GLP-1-Based Therapies.

Journal: Andrology

Published: February 02, 2026

Rethinking Muscle Health Assessment in GLP-1-Based Therapies for Obesity: Beyond Lean Mass.

Rethinking Muscle Health Assessment in GLP-1-Based Therapies for Obesity: Beyond Lean Mass.

Journal: Diabetes, obesity & metabolism

Published: January 21, 2026

Micronutrient Deficiencies in the Era of Second-Generation Incretin-Based Therapies for Obesity.

Micronutrient Deficiencies in the Era of Second-Generation Incretin-Based Therapies for Obesity.

Journal: Nutrients

Published: January 20, 2026

Assessing Europe's policy readiness to confront the MASLD/MASH public health threat.

Assessing Europe's policy readiness to confront the MASLD/MASH public health threat.

Journal: The Lancet regional health. Europe

Published: December 15, 2025

Incretin-Based Anti-obesity Medications in Polycystic Ovary Syndrome: The Evidence Map.

Incretin-Based Anti-obesity Medications in Polycystic Ovary Syndrome: The Evidence Map.

Journal: Drugs

Published: December 05, 2025

Endocrine Adaptations to Prolonged Fasting: From Physiology, Clinical Uncertainties, Translational Challenges to Healthspan Implications.

Endocrine Adaptations to Prolonged Fasting: From Physiology, Clinical Uncertainties, Translational Challenges to Healthspan Implications.

Journal: Nutrients

Published: October 31, 2025

Preconception use of GLP-1 and GLP-1/GIP receptor agonists for obesity treatment.

Preconception use of GLP-1 and GLP-1/GIP receptor agonists for obesity treatment.

Journal: Best practice & research. Clinical endocrinology & metabolism

Published: September 27, 2025

Reframing polycystic ovary syndrome as a complication of obesity: the evolving role of incretin-based therapies.

Reframing polycystic ovary syndrome as a complication of obesity: the evolving role of incretin-based therapies.

Journal: Expert review of endocrinology & metabolism

Published: September 01, 2025

Impact of Incretin-Based Therapy on Skeletal Muscle Health.

Impact of Incretin-Based Therapy on Skeletal Muscle Health.

Journal: Medicina (Kaunas, Lithuania)

Published: August 14, 2025

Showing 1-12 of 93

Last Updated: 09/26/2026